Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.430
+0.230 (5.48%)
At close: May 12, 2025, 4:00 PM
4.400
-0.030 (-0.68%)
After-hours: May 12, 2025, 7:28 PM EDT
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $246.36 million as of May 12, 2025. Its market cap has increased by 11.09% in one year.
Market Cap
246.36M
Enterprise Value
39.75M
1-Year Change
11.09%
Ranking
Category
Stock Price
$4.43
Market Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $246.36M, a decrease of -56.43%. That is a compound annual growth rate of -16.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 233.57M | -10.99% |
| Dec 31, 2024 | 262.40M | -3.64% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | 721.42M | 27.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |